Why Is Archer Aviation Stock Going Up?
Archer Aviation (NYSE:ACHR) is an aviation startup that is working…
Sell
48
USNA Quote, Financials, Valuation and Earnings
Last price:
$30.36
Seasonality move
:
7.28%
Day range:
$30.10 - $30.93
52-week range:
$23.10 - $46.95
Dividend yield:
0%
P/E ratio:
16.68x
P/S ratio:
0.66x
P/B ratio:
1.07x
Volume:
110.3K
Avg. volume:
143.1K
1-year change:
-35.12%
Market cap:
$565.2M
Revenue:
$854.5M
EPS (TTM):
$1.82
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
USNA
Usana Health Sciences
|
$225.2M | $0.54 | 5.79% | -- | $61.00 |
|
ACU
Acme United
|
$58.4M | -- | 5.28% | -- | $50.00 |
|
BTTR
Better Choice
|
-- | -- | -- | -- | $10.00 |
|
HCWC
Healthy Choice Wellness
|
$18.7M | -- | 20% | -- | $2.00 |
|
LSF
Laird Superfood
|
$12.1M | -- | 26.95% | -- | $12.67 |
|
NATR
Natures Sunshine Products
|
$113.1M | $0.17 | 2.31% | 135.71% | $20.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
USNA
Usana Health Sciences
|
$30.35 | $61.00 | $565.2M | 16.68x | $0.00 | 0% | 0.66x |
|
ACU
Acme United
|
$41.61 | $50.00 | $157.7M | 16.98x | $0.16 | 1.47% | 0.87x |
|
BTTR
Better Choice
|
$0.56 | $10.00 | $1.3M | -- | $0.00 | 0% | 0.02x |
|
HCWC
Healthy Choice Wellness
|
$0.43 | $2.00 | $5.2M | -- | $0.00 | 0% | 0.06x |
|
LSF
Laird Superfood
|
$6.73 | $12.67 | $71.1M | -- | $0.00 | 0% | 1.52x |
|
NATR
Natures Sunshine Products
|
$14.87 | $20.50 | $272.9M | 28.06x | $0.00 | 0% | 0.62x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
USNA
Usana Health Sciences
|
4.16% | 0.964 | 4.1% | 1.31x |
|
ACU
Acme United
|
22.06% | 0.832 | 20.6% | 1.71x |
|
BTTR
Better Choice
|
15.88% | -2.844 | 53% | 1.74x |
|
HCWC
Healthy Choice Wellness
|
83.36% | 0.000 | 201.28% | 0.26x |
|
LSF
Laird Superfood
|
-- | 1.334 | -- | 1.16x |
|
NATR
Natures Sunshine Products
|
-- | 2.458 | -- | 1.38x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
USNA
Usana Health Sciences
|
$197.1M | $15.7M | 6.3% | 6.41% | 6.87% | $12.7M |
|
ACU
Acme United
|
$17.9M | $2.4M | 7.31% | 9.57% | 5.54% | -$4.7M |
|
BTTR
Better Choice
|
$4.5M | -$1.1M | -129.81% | -199.75% | -9.91% | -$2.2M |
|
HCWC
Healthy Choice Wellness
|
$7.9M | -$409.7K | -23.86% | -43.51% | -2.05% | $965.3K |
|
LSF
Laird Superfood
|
$4.9M | -$218K | -7.4% | -7.4% | -1.87% | -$1.3M |
|
NATR
Natures Sunshine Products
|
$81.6M | $6.2M | 6.26% | 6.27% | 6.3% | $1.5M |
Usana Health Sciences vs. Competitors
-
Which has Higher Returns USNA or ACU?
Acme United has a net margin of 3.72% compared to Usana Health Sciences's net margin of 3.6%. Usana Health Sciences's return on equity of 6.41% beat Acme United's return on equity of 9.57%.
Company Gross Margin Earnings Per Share Invested Capital USNAUsana Health Sciences78.98% $0.49 $606.9M ACUAcme United38.99% $0.41 $138.9M -
What do Analysts Say About USNA or ACU?
Usana Health Sciences has a consensus price target of $61.00, signalling upside risk potential of 100.99%. On the other hand Acme United has an analysts' consensus of $50.00 which suggests that it could grow by 20.16%. Given that Usana Health Sciences has higher upside potential than Acme United, analysts believe Usana Health Sciences is more attractive than Acme United.
Company Buy Ratings Hold Ratings Sell Ratings USNAUsana Health Sciences0 0 0 ACUAcme United1 0 0 -
Is USNA or ACU More Risky?
Usana Health Sciences has a beta of 0.639, which suggesting that the stock is 36.11% less volatile than S&P 500. In comparison Acme United has a beta of 0.648, suggesting its less volatile than the S&P 500 by 35.162%.
-
Which is a Better Dividend Stock USNA or ACU?
Usana Health Sciences has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Acme United offers a yield of 1.47% to investors and pays a quarterly dividend of $0.16 per share. Usana Health Sciences pays -- of its earnings as a dividend. Acme United pays out 22.17% of its earnings as a dividend. Acme United's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios USNA or ACU?
Usana Health Sciences quarterly revenues are $249.5M, which are larger than Acme United quarterly revenues of $46M. Usana Health Sciences's net income of $9.3M is higher than Acme United's net income of $1.7M. Notably, Usana Health Sciences's price-to-earnings ratio is 16.68x while Acme United's PE ratio is 16.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Usana Health Sciences is 0.66x versus 0.87x for Acme United. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income USNAUsana Health Sciences0.66x 16.68x $249.5M $9.3M ACUAcme United0.87x 16.98x $46M $1.7M
-
Which has Higher Returns USNA or BTTR?
Better Choice has a net margin of 3.72% compared to Usana Health Sciences's net margin of 13.42%. Usana Health Sciences's return on equity of 6.41% beat Better Choice's return on equity of -199.75%.
Company Gross Margin Earnings Per Share Invested Capital USNAUsana Health Sciences78.98% $0.49 $606.9M BTTRBetter Choice39.73% $0.73 $12.2M -
What do Analysts Say About USNA or BTTR?
Usana Health Sciences has a consensus price target of $61.00, signalling upside risk potential of 100.99%. On the other hand Better Choice has an analysts' consensus of $10.00 which suggests that it could grow by 1700.18%. Given that Better Choice has higher upside potential than Usana Health Sciences, analysts believe Better Choice is more attractive than Usana Health Sciences.
Company Buy Ratings Hold Ratings Sell Ratings USNAUsana Health Sciences0 0 0 BTTRBetter Choice1 0 0 -
Is USNA or BTTR More Risky?
Usana Health Sciences has a beta of 0.639, which suggesting that the stock is 36.11% less volatile than S&P 500. In comparison Better Choice has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.427%.
-
Which is a Better Dividend Stock USNA or BTTR?
Usana Health Sciences has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Better Choice offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Usana Health Sciences pays -- of its earnings as a dividend. Better Choice pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios USNA or BTTR?
Usana Health Sciences quarterly revenues are $249.5M, which are larger than Better Choice quarterly revenues of $11.4M. Usana Health Sciences's net income of $9.3M is higher than Better Choice's net income of $1.5M. Notably, Usana Health Sciences's price-to-earnings ratio is 16.68x while Better Choice's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Usana Health Sciences is 0.66x versus 0.02x for Better Choice. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income USNAUsana Health Sciences0.66x 16.68x $249.5M $9.3M BTTRBetter Choice0.02x -- $11.4M $1.5M
-
Which has Higher Returns USNA or HCWC?
Healthy Choice Wellness has a net margin of 3.72% compared to Usana Health Sciences's net margin of -3.52%. Usana Health Sciences's return on equity of 6.41% beat Healthy Choice Wellness's return on equity of -43.51%.
Company Gross Margin Earnings Per Share Invested Capital USNAUsana Health Sciences78.98% $0.49 $606.9M HCWCHealthy Choice Wellness38.76% -$0.07 $12.8M -
What do Analysts Say About USNA or HCWC?
Usana Health Sciences has a consensus price target of $61.00, signalling upside risk potential of 100.99%. On the other hand Healthy Choice Wellness has an analysts' consensus of $2.00 which suggests that it could grow by 365.12%. Given that Healthy Choice Wellness has higher upside potential than Usana Health Sciences, analysts believe Healthy Choice Wellness is more attractive than Usana Health Sciences.
Company Buy Ratings Hold Ratings Sell Ratings USNAUsana Health Sciences0 0 0 HCWCHealthy Choice Wellness0 0 0 -
Is USNA or HCWC More Risky?
Usana Health Sciences has a beta of 0.639, which suggesting that the stock is 36.11% less volatile than S&P 500. In comparison Healthy Choice Wellness has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock USNA or HCWC?
Usana Health Sciences has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthy Choice Wellness offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Usana Health Sciences pays -- of its earnings as a dividend. Healthy Choice Wellness pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios USNA or HCWC?
Usana Health Sciences quarterly revenues are $249.5M, which are larger than Healthy Choice Wellness quarterly revenues of $20.3M. Usana Health Sciences's net income of $9.3M is higher than Healthy Choice Wellness's net income of -$712.4K. Notably, Usana Health Sciences's price-to-earnings ratio is 16.68x while Healthy Choice Wellness's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Usana Health Sciences is 0.66x versus 0.06x for Healthy Choice Wellness. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income USNAUsana Health Sciences0.66x 16.68x $249.5M $9.3M HCWCHealthy Choice Wellness0.06x -- $20.3M -$712.4K
-
Which has Higher Returns USNA or LSF?
Laird Superfood has a net margin of 3.72% compared to Usana Health Sciences's net margin of -1.34%. Usana Health Sciences's return on equity of 6.41% beat Laird Superfood's return on equity of -7.4%.
Company Gross Margin Earnings Per Share Invested Capital USNAUsana Health Sciences78.98% $0.49 $606.9M LSFLaird Superfood41.89% -$0.02 $13.3M -
What do Analysts Say About USNA or LSF?
Usana Health Sciences has a consensus price target of $61.00, signalling upside risk potential of 100.99%. On the other hand Laird Superfood has an analysts' consensus of $12.67 which suggests that it could grow by 88.21%. Given that Usana Health Sciences has higher upside potential than Laird Superfood, analysts believe Usana Health Sciences is more attractive than Laird Superfood.
Company Buy Ratings Hold Ratings Sell Ratings USNAUsana Health Sciences0 0 0 LSFLaird Superfood1 0 0 -
Is USNA or LSF More Risky?
Usana Health Sciences has a beta of 0.639, which suggesting that the stock is 36.11% less volatile than S&P 500. In comparison Laird Superfood has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock USNA or LSF?
Usana Health Sciences has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Laird Superfood offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Usana Health Sciences pays -- of its earnings as a dividend. Laird Superfood pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios USNA or LSF?
Usana Health Sciences quarterly revenues are $249.5M, which are larger than Laird Superfood quarterly revenues of $11.7M. Usana Health Sciences's net income of $9.3M is higher than Laird Superfood's net income of -$156.2K. Notably, Usana Health Sciences's price-to-earnings ratio is 16.68x while Laird Superfood's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Usana Health Sciences is 0.66x versus 1.52x for Laird Superfood. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income USNAUsana Health Sciences0.66x 16.68x $249.5M $9.3M LSFLaird Superfood1.52x -- $11.7M -$156.2K
-
Which has Higher Returns USNA or NATR?
Natures Sunshine Products has a net margin of 3.72% compared to Usana Health Sciences's net margin of 4.19%. Usana Health Sciences's return on equity of 6.41% beat Natures Sunshine Products's return on equity of 6.27%.
Company Gross Margin Earnings Per Share Invested Capital USNAUsana Health Sciences78.98% $0.49 $606.9M NATRNatures Sunshine Products72.05% $0.25 $167.1M -
What do Analysts Say About USNA or NATR?
Usana Health Sciences has a consensus price target of $61.00, signalling upside risk potential of 100.99%. On the other hand Natures Sunshine Products has an analysts' consensus of $20.50 which suggests that it could grow by 37.86%. Given that Usana Health Sciences has higher upside potential than Natures Sunshine Products, analysts believe Usana Health Sciences is more attractive than Natures Sunshine Products.
Company Buy Ratings Hold Ratings Sell Ratings USNAUsana Health Sciences0 0 0 NATRNatures Sunshine Products2 0 0 -
Is USNA or NATR More Risky?
Usana Health Sciences has a beta of 0.639, which suggesting that the stock is 36.11% less volatile than S&P 500. In comparison Natures Sunshine Products has a beta of 1.139, suggesting its more volatile than the S&P 500 by 13.935%.
-
Which is a Better Dividend Stock USNA or NATR?
Usana Health Sciences has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natures Sunshine Products offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Usana Health Sciences pays -- of its earnings as a dividend. Natures Sunshine Products pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios USNA or NATR?
Usana Health Sciences quarterly revenues are $249.5M, which are larger than Natures Sunshine Products quarterly revenues of $113.2M. Usana Health Sciences's net income of $9.3M is higher than Natures Sunshine Products's net income of $4.7M. Notably, Usana Health Sciences's price-to-earnings ratio is 16.68x while Natures Sunshine Products's PE ratio is 28.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Usana Health Sciences is 0.66x versus 0.62x for Natures Sunshine Products. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income USNAUsana Health Sciences0.66x 16.68x $249.5M $9.3M NATRNatures Sunshine Products0.62x 28.06x $113.2M $4.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
